Himadri Speciality Chemical is back on investor radars after analysts lifted their fair value estimate for the stock from ₹470 to ₹550. This change is being framed as a recalibration of the valuation framework, with new commentary focused on how updated assumptions might shift the risk and reward balance for shareholders. Read on to see what this evolving narrative could mean for how you track the stock from here. Analyst Price Targets don't always capture the full story. Head over to our...